Anti-Cyclic Citrullinated Peptide Frequency in Patients with Chronic Hepatitis C Virus Infection and Effect of Presence of Systemic Disease | Zendy

Ayşe Albayrak | Zendy; Hakan Dursun | Zendy; M. Hamidullah Uyanık | Zendy; Serkan Cerrah | Zendy

Open Access

Anti-Cyclic Citrullinated Peptide Frequency in Patients with Chronic Hepatitis C Virus Infection and Effect of Presence of Systemic Disease

Author(s) -

Ayşe Albayrak,

Hakan Dursun,

M. Hamidullah Uyanık,

Serkan Cerrah

Publication year - 2012

Publication title -

eurasian journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.337

H-Index - 13

eISSN - 1308-8742

pISSN - 1308-8734

DOI - 10.5152/eajm.2012.31

Subject(s) - medicine , familial mediterranean fever , rheumatoid arthritis , antibody , immunology , psoriatic arthritis , primary biliary cirrhosis , chronic liver disease , hepatitis c virus , cirrhosis , gastroenterology , disease , virus

Patients with chronic hepatitis C virus (HCV) infection may show a variety of rheumatic symptoms and signs. Anti-cyclic citrullinated peptide (anti-CCP) is widely used as as a marker, particularly for rheumatoid arthritis (RA), and may be positive in some diseases that also cause arthritis, such as systemic lupus erythematosus, familial Mediterranean fever, Behçet's disease, and psoriatic arthritis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research